Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 11, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-10
DOI
10.1038/s41408-021-00417-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
- (2021) Tiziano Barbui et al. LEUKEMIA
- Incidence of myeloproliferative neoplasms – trends by subgroup and age in a population‐based study in Sweden
- (2020) M. Hultcrantz et al. JOURNAL OF INTERNAL MEDICINE
- Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map
- (2020) Rory M. Shallis et al. BLOOD REVIEWS
- Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
- (2020) Alex C. Spyropoulos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
- (2020) Mathieu Artifoni et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
- (2020) Hanny Al-Samkari et al. BLOOD
- The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
- (2020) Jatin Machhi et al. Journal of Neuroimmune Pharmacology
- Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic
- (2020) Benjamin Marchandot et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
- (2020) Luca Carsana et al. LANCET INFECTIOUS DISEASES
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
- (2020) Corrado Lodigiani et al. THROMBOSIS RESEARCH
- COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
- (2020) Razie Amraei et al. Cells
- The Impact of COVID-19 Disease on Platelets and Coagulation
- (2020) Geoffrey D. Wool et al. PATHOBIOLOGY
- Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS
- (2020) Katharina Mueller-Peltzer et al. RESPIRATORY MEDICINE
- Covid-19 and in situ pulmonary artery thrombosis
- (2020) Amit K.J. Mandal et al. RESPIRATORY MEDICINE
- Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
- (2020) Cristina Rodríguez et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
- (2019) Tarinee Rungjirajittranon et al. BMC CANCER
- Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms
- (2018) Malin Hultcrantz et al. ANNALS OF INTERNAL MEDICINE
- Myeloproliferative neoplasms and thrombosis
- (2013) T. Barbui et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started